A randomized, double-blind, placebo controlled, multicenter, parallel-arm study assessing the efficacy, safety, and dose-response of ramipril for the treatment of hypertension in children and adolescents

Trial Profile

A randomized, double-blind, placebo controlled, multicenter, parallel-arm study assessing the efficacy, safety, and dose-response of ramipril for the treatment of hypertension in children and adolescents

Discontinued
Phase of Trial: Phase III

Latest Information Update: 08 Jun 2012

At a glance

  • Drugs Ramipril (Primary)
  • Indications Hypertension
  • Focus Therapeutic Use
  • Acronyms TOPHAT-II
  • Sponsors King Pharmaceuticals
  • Most Recent Events

    • 15 Apr 2009 Results presented at PAS 2009.
    • 08 Feb 2008 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 03 Dec 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top